James F. Oliviero
2013
In 2013, James F. Oliviero earned a total compensation of $2.3M as Former Chief Financial Officer at Keryx Biopharmaceuticals, a 316% increase compared to previous year.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Non-Equity Incentive Plan | $106,000 |
| Option Awards | $107,654 |
| Salary | $265,000 |
| Stock Awards | $1,644,186 |
| Total | $2,262,840 |
Oliviero received $1.6M in stock awards, accounting for 73% of the total pay in 2013.
Oliviero also received $140K in bonus, $106K in non-equity incentive plan, $107.7K in option awards and $265K in salary.
Rankings
In 2013, James F. Oliviero's compensation ranked 3,473rd out of 12,286 executives tracked by ExecPay. In other words, Oliviero earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,473 out of 12,286 | 72nd |
Division Manufacturing | 1,172 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 316 out of 1,466 | 78th |
Industry group Drugs | 219 out of 1,160 | 81st |
Industry Pharmaceutical Preparations | 181 out of 890 | 80th |
Source: SEC filing on April 15, 2016.
Oliviero's colleagues
We found one more compensation record of an executive who worked with James F. Oliviero at Keryx Biopharmaceuticals in 2013.
2013
Ron Bentsur
Keryx Biopharmaceuticals